Entrada Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRDA and other ETFs, options, and stocks.About TRDA
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index.
TRDA Key Statistics
Stock Snapshot
With a market cap of 246.9M, Entrada Therapeutics(TRDA) trades at $6.37. The stock has a price-to-earnings ratio of -1.57.
On 2026-06-09, Entrada Therapeutics(TRDA) stock moved within a range of $6.15 to $6.69. With shares now at $6.37, the stock is trading +3.6% above its intraday low and -4.8% below the session's peak.
Trading activity shows a volume of 174.09K, compared to an average daily volume of 302.2K.
The stock's 52-week range extends from a low of $4.93 to a high of $16.45.
The stock's 52-week range extends from a low of $4.93 to a high of $16.45.
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.